this post was submitted on 21 Oct 2023
2136 points (97.5% liked)

Technology

60086 readers
2769 users here now

This is a most excellent place for technology news and articles.

Our Rules

  1. Follow the lemmy.world rules.
  2. Only tech related content.
  3. Be excellent to each another!
  4. Mod approved content bots can post up to 10 articles per day.
  5. Threads asking for personal tech support may be deleted.
  6. Politics threads may be removed.
  7. No memes allowed as posts, OK to post as comments.
  8. Only approved bots from the list below, to ask if your bot can be added please contact us.
  9. Check for duplicates before posting, duplicates may be removed

Approved Bots

founded 2 years ago
MODERATORS
[email protected]
[email protected]
[email protected]
[email protected]
[email protected]
2136
Pfizer says it will price Covid treatment Paxlovid at nearly $1,400 for a five-day course, which researchers estimate only costs Pfizer $13 to produce. That's a 10,000%+ markup. Shameful. (mastodon.world)
submitted 1 year ago by [email protected] to c/[email protected]
292 comments fedilink hide all child comments
you are viewing a single comment's thread
view the rest of the comments
[–] [email protected] 2 points 1 year ago (1 children)

The clinical trials are the most costly and most risky part of development.

[–] [email protected] -2 points 1 year ago (1 children)

From the passage I already quoted:

In reality, public sources — especially the NIH — fund the basic research that makes scientific breakthroughs. Then small, boutique biotech and pharmaceutical firms take that publicly generated knowledge and do the final stages of research, like running clinical trials, that get the drugs to market.

[–] [email protected] 4 points 1 year ago* (last edited 1 year ago) (1 children)

That is not true. Small biotech usually cannot effort late stage development. They either just get buyed by big pharma. Or they licence the lead compound to big pharma and get royalties. Very few exemptions to this.

Edit: the link you provide cites this FT article as a source for this claim. However the article is about M&A and supports my point.

[–] [email protected] 0 points 1 year ago (1 children)

I'll assume you know more about this than I do despite the lack of any citation.

I refuse to believe there's an ethically acceptable business justification for this ridiculous markup.

The entire healthcare industry in the US is built on a foundation of corporate greed. This is just one obvious example.

[–] [email protected] 1 points 1 year ago

At least they loose exclusivity after 15 -20 years and generics are usually much cheaper.